by Jason Heaviland | Apr 21, 2026
Decoding Alzheimer’s Disease with Multi-Omics Alzheimer’s disease involves coordinated changes across metabolism, proteins and cellular systems. By combining metabolomics and proteomics, this study examines how these changes relate within the same biological...
by Jason Heaviland | Apr 15, 2026
This study presents an integrated proteomics and metabolomics analysis of Alzheimer’s disease using serum samples. Across 11,000+ molecular features, Panome Bio identified systemic metabolic dysregulation, lipid transport disruption, and protein-level changes...
by Jason Heaviland | Mar 31, 2026
Metabolomics Comparison: A Head-to-Head Study Panome Bio conducted a controlled head-to-head metabolomics study using identical samples analyzed by a legacy library-based platform and Next-Generation Metabolomics®️. The results show a nearly 4× increase in detected...
by Jason Heaviland | Mar 25, 2026
Pinpointing the Pervasive: Exposomics Analysis of Alzheimer’s Disease This poster presents a comprehensive exposomics analysis of Alzheimer’s disease, leveraging both targeted and discovery workflows to characterize environmental exposures and their biological impact....
by Jason Heaviland | Mar 2, 2026
Exposomics Measuring Chemical Drivers of Human Disease Panome Bio’s Exposomics platform enables comprehensive measurement of chemical exposures that drive human disease. Using integrated discovery (32,000+ compounds) and targeted profiling (235 priority chemicals), we...
